Chemed Corp. Company Profile (NYSE:CHE)

Analyst Ratings

Consensus Ratings for Chemed Corp. (NYSE:CHE) (?)
Ratings Breakdown: 2 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $156.33 (6.25% upside)

Analysts' Ratings History for Chemed Corp. (NYSE:CHE)
Show:
DateFirmActionRatingPrice TargetActions
7/27/2016RBC Capital MarketsReiterated RatingSector Perform$136.00 -> $162.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/27/2016Royal Bank Of CanadaBoost Price TargetSector Perform$136.00 -> $162.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2016Oppenheimer Holdings Inc.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/15/2015Deutsche Bank AGReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/29/2014 forward)

Earnings

Earnings History for Chemed Corp. (NYSE:CHE)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
10/20/2016        
7/25/2016Q216$1.72$1.80$393.50 million$290.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/28/2016Q116$1.58$1.62$391.68 million$390.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/17/2016Q415$1.81$1.97$390.22 million$398.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/22/2015Q315$1.61$1.78$375.95 million$386.23 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/23/2015Q215$1.59$1.71$375.01 million$382.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/28/2015Q115$1.44$1.54$370.76 million$377.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/17/2015Q414$1.69$1.80$372.54 million$379.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2014Q314$1.51$1.48$360.00 million$358.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/23/2014Q214$1.47$1.50$363.73 million$360.18 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/29/2014Q114$1.32$1.32$256.77 million$358.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2013Q313$1.34$1.36$355.40 million$340.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/18/2013Q2 2013$1.33$1.44$368.06 million$357.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/18/2013Q1 2013$1.29$1.38$365.08 million$367.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/18/2013Q4 2012$1.15$1.57$355.31 million$369.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2012Q312$1.35$1.28$360.50 million$354.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/25/2012$1.26$1.26ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/19/2012$1.25$1.21ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/14/2012$1.48$1.45ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/25/2011$1.15$1.20ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/26/2011$0.98$1.07ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/15/2011$1.05$0.98ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Chemed Corp. (NYSE:CHE)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$1.58$1.58$1.58
Q2 20161$1.74$1.74$1.74
Q3 20161$1.80$1.80$1.80
Q4 20161$2.08$2.08$2.08
Q1 20172$1.76$1.83$1.80
Q2 20171$1.90$1.90$1.90
Q3 20171$1.95$1.95$1.95
Q4 20171$2.24$2.24$2.24
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Chemed Corp. (NYSE:CHE)
Annual Dividend:$0.96
Dividend Yield:0.65%
Payout Ratio:15.24% (Based on Trailing 12 Months of Earnings)
13.22% (Based on Current Year Consensus EPS Estimate)
12.37% (Based on Next Year Consensus EPS Estimate)
Dividend Growth:10.60% (3 Year Average)

Dividend History for Chemed Corp. (NYSE:CHE)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
5/16/2016quarterly$0.240.76%5/24/20165/26/20166/15/2016Tweet This Announcement  Share This Announcement on StockTwits
2/19/2016quarterly$0.240.75%2/25/20162/29/20163/21/2016Tweet This Announcement  Share This Announcement on StockTwits
11/6/2015quarterly$0.240.63%11/12/201511/16/201512/7/2015Tweet This Announcement  Share This Announcement on StockTwits
8/7/2015quarterly$0.240.63%8/13/20158/17/20159/4/2015Tweet This Announcement  Share This Announcement on StockTwits
5/18/2015quarterly$0.220.71%5/26/20155/28/20156/17/2015Tweet This Announcement  Share This Announcement on StockTwits
2/20/2015quarterly$0.220.77%2/26/20153/2/20153/23/2015Tweet This Announcement  Share This Announcement on StockTwits
11/7/2014quarterly$0.220.81%11/13/201411/17/201412/8/2014Tweet This Announcement  Share This Announcement on StockTwits
8/11/2014quarterly$0.220.88%8/14/20148/18/20149/13/2014Tweet This Announcement  Share This Announcement on StockTwits
8/8/2014quarterly$0.228/14/20148/18/20149/3/2014Tweet This Announcement  Share This Announcement on StockTwits
5/19/2014quarterly$0.200.91%5/27/20145/29/20146/18/2014Tweet This Announcement  Share This Announcement on StockTwits
2/21/2014quarterly$0.200.94%2/27/20143/3/20143/24/2014Tweet This Announcement  Share This Announcement on StockTwits
11/8/2013quarterly$0.201.13%11/14/201311/18/201312/9/2013Tweet This Announcement  Share This Announcement on StockTwits
8/2/2013quarterly$0.201.1%8/8/20138/12/20139/3/2013Tweet This Announcement  Share This Announcement on StockTwits
5/20/2013quarterly$0.181.05%5/28/20135/30/20136/19/2013Tweet This Announcement  Share This Announcement on StockTwits
2/20/2013quarterly$0.180.92%2/28/20133/4/20133/22/2013Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Chemed Corp. (NYSE:CHE)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/16/2016Donald E SaundersDirectorBuy77$126.53$9,742.81View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/21/2016Spencer S LeeEVPSell24,382$132.29$3,225,494.78View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/27/2016Patrick P GraceDirectorSell50$138.98$6,949.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/11/2015David Patrick WilliamsCFOSell5,000$151.72$758,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/24/2015Spencer S LeeEVPSell5,000$154.10$770,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/6/2015Kevin J McnamaraCEOSell6,000$157.02$942,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/27/2015Spencer S. LeeEVPSell4,000$153.64$614,560.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/26/2015Kevin J. McnamaraCEOSell8,000$149.04$1,192,320.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/24/2015David Patrick WilliamsCFOSell10,000$138.09$1,380,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2015Arthur V Tucker JrVPSell9,000$121.00$1,089,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/7/2015Kevin J McnamaraCEOSell8,000$120.82$966,560.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/6/2015Spencer S LeeEVPSell9,931$115.16$1,143,653.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015Timothy S OtooleEVPSell10,000$117.82$1,178,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/27/2015Arthur V Tucker JrVPSell7,000$116.80$817,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2015Arthur V Tucker JrVPSell2,685$114.35$307,029.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/23/2015Spencer S LeeEVPSell10,000$113.18$1,131,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/20/2015Kevin J McnamaraCEOSell13,000$112.71$1,465,230.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/14/2014Timothy S OtooleEVPSell5,000$106.81$534,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2014Spencer S LeeEVPSell10,000$108.38$1,083,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/4/2014Kevin J McnamaraCEOSell4,000$104.13$416,520.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2014Spencer S LeeEVPSell2,000$105.80$211,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2014David Patrick WilliamsCFOSell5,000$105.90$529,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2014Kevin J McnamaraCEOSell5,000$100.05$500,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/25/2014Arthur V Tucker JrVPSell9,000$101.26$911,340.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/25/2014Kevin J McnamaraCEOSell10,000$101.00$1,010,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2014Timothy OtooleEVPSell9,000$87.62$788,580.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/5/2014Kevin McnamaraCEOSell5,000$85.05$425,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/2/2014Spencer LeeEVPSell2,000$90.15$180,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/19/2014Thomas HuttonVPSell2,201$88.36$194,480.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2014Timothy OtooleEVPSell6,000$86.60$519,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2014Kevin McnamaraCEOSell4,000$84.47$337,880.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/28/2014Arthur Tucker, Jr.VPSell9,000$85.01$765,090.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2014Arthur Tucker, Jr.VPSell8,461$83.80$709,031.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/20/2014Spencer LeeEVPSell2,000$82.51$165,020.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/19/2014Kevin McnamaraCEOSell4,000$82.18$328,720.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Chemed Corp. (NYSE:CHE)
DateHeadline
07/27/16 11:46 AMChemed Reports Second-Quarter 2016 Results
07/27/16 11:46 AMBRIEF-Chemed Corp Q2 shr $1.48
07/27/16 11:46 AMChemed Corp. Q2 Profit Advances 2%
07/27/16 11:46 AMChemed's (CHE) CEO Kevin McNamara on Q2 2016 Results - Earnings Call Transcript
07/26/16 03:24 PMEdited Transcript of CHE earnings conference call or presentation 26-Jul-16 2:00pm GMT -
07/26/16 09:59 AMChemed (CHE) Lags Q2 Earnings, Tops Revenues, View Up -
07/26/16 09:00 AMChemed Corp Earnings Call scheduled for 10:00 am ET today -
07/25/16 03:29 PMChemed posts 2Q profit -
07/25/16 06:07 AMQ2 2016 Chemed Corp Earnings Release - After Market Close -
07/22/16 08:53 AMMedical Stocks Reporting Early Next Week: GILD, LLY & More -
07/20/16 04:19 PMChemed Corporation : half-yearly earnings release
07/19/16 03:16 PMAcadian Asset Management LLC Buys A Little More Chemed Corp (CHE) Stock In The Last Quarter
07/08/16 11:01 AMChemed To Report Second-Quarter 2016 Earnings July 25, Related Conference Call To Be Held On July 26 - [at noodls] - CINCINNATI--(BUSINESS WIRE)--Jul. 8, 2016-- Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the second quarter ended June 30, 2016, on Monday, July 25, 2016, following ...
06/28/16 07:23 AMChemed Corp. breached its 50 day moving average in a Bearish Manner : CHE-US : June 28, 2016 -
06/13/16 07:35 AMChemed Corp. breached its 50 day moving average in a Bearish Manner : CHE-US : June 13, 2016 -
06/09/16 06:01 AMCHEMED CORP Files SEC form 8-K, Change in Directors or Principal Officers -
06/09/16 02:39 AMCherkizovo Group PJSC :CHE-GB: Earnings Analysis: Q1, 2016 By the Numbers : June 9, 2016 -
06/08/16 04:18 PMChemed Corporation Announces the Retirement of Timothy S. O’Toole - [at noodls] - CINCINNATI--(BUSINESS WIRE)--Jun. 8, 2016-- After more than a decade of leading VITAS Healthcare Corporation to become the single largest hospice provider in America, Chief Executive Officer Timothy S. ...
06/02/16 07:14 AMChemed Corp. breached its 50 day moving average in a Bullish Manner : CHE-US : June 2, 2016 -
05/31/16 01:53 PMChemed Corporation to Present at the Jefferies 2016 Global Healthcare Conference - [at noodls] - CINCINNATI--(BUSINESS WIRE)--May 31, 2016-- Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Jefferies 2016 Global Healthcare Conference onTuesday, June 7, 2016, ...
05/18/16 10:14 AMCHEMED CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
05/16/16 02:42 PMChemed Corporation Holds Annual Meeting of Shareholders; Board Declares Quarterly Dividend - [at noodls] - CINCINNATI--(BUSINESS WIRE)--May 16, 2016-- Shareholders of Chemed Corporation (NYSE:CHE) today elected a slate of 10 directors at the Company's 2016 annual shareholders' meeting. Each of the directors ...
05/05/16 02:01 PMChemed Corporation to Present at the Bank of America Merrill Lynch 2016 Health Care Conference - [at noodls] - CINCINNATI--(BUSINESS WIRE)--May 5, 2016-- Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Merrill Lynch 2016 Health Care Conference on Wednesday, ...
05/03/16 09:59 AMChemed Corp. :CHE-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/02/16 10:17 AMCHEMED CORP Files SEC form 10-Q, Quarterly Report -
05/02/16 09:53 AMChemed (CHE) Q1 Earnings Miss the Mark, Revenues in Line -
04/29/16 08:01 PMEdited Transcript of CHE earnings conference call or presentation 29-Apr-16 2:00pm GMT -
04/29/16 07:17 AMChemed Corp. breached its 50 day moving average in a Bearish Manner : CHE-US : April 29, 2016 -
04/28/16 05:53 PMChemed posts 1Q profit -
04/28/16 03:36 PMChemed Reports First-Quarter 2016 Results - [at noodls] - Chemed Reports First-Quarter 2016 Results
04/28/16 06:07 AMQ1 2016 Chemed Corp Earnings Release - After Market Close -
04/15/16 02:27 PMChemed To Report First-Quarter 2016 Earnings April 28, Related Conference Call To Be Held On April 29 - [at noodls] - CINCINNATI--(BUSINESS WIRE)--Apr. 15, 2016-- Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the first quarter ended March 31, 2016, on Thursday, April 28, 2016, ...
04/02/16 01:34 PMCHEMED CORP. (NYSE:CHE): Analysts Maintain an average rating of Buy - Hints News Network - CHEMED CORP. (NYSE:CHE): Analysts Maintain an average rating of BuyHints News NetworkCHEMED CORP. (NYSE:CHE) received a 'Buy' rating on average from equities analysts who cover the company. The rating was compiled from from the 2 investment firms that maintain analyst coverage on the company. 1 analyst currently rates the company ...and more »
03/15/16 11:50 AMBellicum Pharmaceuticals' (BLCM) CEO Tom Farrell on Q4 2015 Results - Earnings Call Transcript - Thank you, Chemed. Good afternoon everyone and thank you for joining ... Unlike standard CARs, which is depended on antigen for activation and proliferation, GoCAR-T places the co-stimulatory signal on the rimiducid controlled switch which designed to ...
03/14/16 04:20 PMWill Cincinnati firm’s $100M expenditure benefit shareholders? -
03/14/16 07:31 AMCHEMED CORP Files SEC form 8-K, Other Events -
03/14/16 07:00 AMChemed Corporation’s Board of Directors Authorizes an Additional $100 Million for Stock Repurchase - [Business Wire] - Chemed Corporation announced today that the Board of Directors has formally authorized an additional $100 million for stock repurchase under Chemed’s existing share repurchase program.
03/04/16 09:56 AMChemed (CHE): Moving Average Crossover Alert -
02/23/16 10:29 AMChemed Corp. Earnings Analysis: 2015 By the Numbers -
02/18/16 11:48 AMEdited Transcript of CHE earnings conference call or presentation 18-Feb-16 3:00pm GMT -
02/18/16 11:10 AMChemed Beats Q4 Earnings, Revenues; Cash Balance Strong -
12/08/15 07:32 PMHusky Energy Lowers Break Even to Sub-$40 US WTI, Announces 2016 Guidance -
12/02/15 03:53 AMCKI Wins Edison Electric Institute's Asian Index Award -
11/18/15 07:31 PMHusky Energy Approves New Heavy Oil Thermal Project -
11/09/15 07:06 PMHusky Achieves Milestone with Madura Strait BD Gas Development -
11/05/15 01:20 PMChemed Corporation to Present at the 2015 Credit Suisse Healthcare Conference -
11/01/15 10:36 PMHusky Takes Action to Improve Resiliency and Fortify Business, Announces Third Quarter Results -
11/01/15 10:36 PMHusky Energy Announces 2015 Third Quarter Dividends -
10/08/15 02:55 PMChemed To Report Third-Quarter 2015 Earnings October 22, Related Conference Call To Be Held On October 23 -
10/07/15 08:24 PMNew Proposal for CKI and PAH Merger -

Social

About Chemed Corp.

Chemed Corp. logoChemed Corporation operates and divests subsidiaries engaged in diverse business activities. The Company operates its business in two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company's VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. VITAS segment provides hospice care to Medicare beneficiaries receiving their non-hospice healthcare services from health maintenance organizations (HMOs) under Medicare risk contracts. The Company and its subsidiaries also own training manuals, cost information, patient information and software source codes. A portion of its VITAS business is operated in the state of Florida. The Company's Roto-Rooter segment provides plumbing, drain cleaning, water restoration and other related services to both residential and commercial customers.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Home Health Care
  • Sub-Industry: Health Care Services
  • Exchange: NYSE
  • Symbol: CHE
  • CUSIP: 16359R10
Key Metrics:
  • Previous Close: $147.24
  • 50 Day Moving Average: $137.02
  • 200 Day Moving Average: $134.44
  • P/E Ratio: 23.35
  • P/E Growth: 2.04
  • Market Cap: $2.42B
  • Beta: 1.13
  • Current Year EPS Consensus Estimate: $7.26 EPS
  • Next Year EPS Consensus Estimate: $7.76 EPS
Additional Links:
Chemed Corp. (NYSE:CHE) Chart for Friday, July, 29, 2016